Pascal Tricuspid Repair Outcomes Durable at 1 Year: CLASP-TR

Three-fourths of patients had at least a two-grade reduction in tricuspid regurgitation, and 88% were alive 1 year after treatment with the experimental device.
Medscape Medical News
Three-fourths of patients had at least a two-grade reduction in tricuspid regurgitation, and 88% were alive 1 year after treatment with the experimental device.
Medscape Medical News